Skip to content

Clinical trials

Phase 3 Vaso-Occlusive Crises trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Vaso-Occlusive Crises Phase: Phase 3 Country / region: France Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20214
20221
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting2
Terminated2
Completed1
Not yet recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer2
Forma Therapeutics, Inc.1
Nantes University Hospital1
Novartis Pharmaceuticals1
University Hospital, Bordeaux1
University Hospital, Geneva1
University Hospital, Rouen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Vaso-Occlusive Crises8
Anemia, Sickle Cell7
Hematologic Diseases4
Sickle Cell Trait4
Agnosia2
Acute Chest Syndrome1
Anemia1
Anemia, Hemolytic1
Genetic Diseases, Inborn1
Hemoglobinopathies1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.